Cardiovascular regeneration therapies using tissue engineering approaches
著者
書誌事項
Cardiovascular regeneration therapies using tissue engineering approaches
Springer, c2005
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The cardiovascular system transports oxygen and nutrients to all parts of the body; therefore, any impediment to this system through, for example, a circulatory disorder, represents a serious threat to organs, tissues, and cells. Obstructive diseases of vessels with a diameter of more than 1 mm can be treated by conventional surgical and interventional approaches; however, blockages in small vessels with a diameter of less than 1 mm cannot be treated by conventional methods. As a consequence, therapeutic ang- genesis and vasculogenesis for the treatment of ischemic diseases have been widely studied in the last decade. These methods may contribute to the re pair of intractable cardiovascular diseases with a main vascular involvement in the body's smallest vessels. In this book, Hikaru Matsuda and I have tried to summarize recent Japanese developments in the field of cardiovascular regeneration therapies using tissue engineering. The Ministry of Health, Labor, and Welfare of Japan has been encouraging the National Cardiovascular Center Research Institute to promote cardiovascular regeneration therapies using such ap proaches. Therefore, it is with the financial aid and support of research grants, such as that for Cardiovascular Disease (13C-1 and I6C-6), Health and Labor Sciences Research Grants (RHGTEFB-genome-005, RHGTEFB-saisei-003, and CRCD-junkanki-009) and a grant from NEDO of Japan, that significant progress has been possible.
目次
- Vascular Precursor Cells and Their Potentiation: EPC and Their Potentiation by Adenovirus Gene Delivery
- Potentiation of Regenerative Therapy by Non-Viral Vector, Gelatin Hydrogel
- Regeneration of Myocardium Using Bone Marrow Cells.- Development of Myocardial Sheets and Their Cell Sources: Cell Sheet Technology for Myocardial Tissue Engineering
- Myocardial Regeneration Therapy with Tissue Implantation of Autologous Myoblast Sheets for Severe Impaired Heart Failure
- Cardiovascular Cell Differentiation from ES Cells.- Hybrid Tissues: Preparation and Recellularization of Tissue-Engineered Bioscaffold or Heart Valve Replacement
- Biotube Technology for a Novel Tissue-Engineered Blood Vessels
- Clinical Application of Tissue-Engineered Blood Vessels.- New Aspects of Angiogenesis: Vascular Regeneration and Remodeling by Circulating Progenitor Cells
- Gene Therapy with Hepatocyte Growth Factor for Angiogenesis in Severe Pulmonary Vascular Disease
- Basic Fibroblast Growth Factor and Angiogenesis
- Gene Therapy for Angiogenesis under a Ventricular Assist System
- The Role of Vascular Endothelial Growth Factor (VEGF) on Therapeutic Angiogenesis Using Bone Marrow Cells.- Clinical Results of Therapeutic Angiogenesis and Vasculogenesis: Clinical Survey of Cell Therapy in Japan
- A Novel Micro-Angiography Detecting Angiogenesis, Application for Autologous Bone Marrow Mononuclear Cells Transplantation in the Patients with Critical Limb Ischemia
- Angiogenesis Induced by Intramyocardial Implantation of Autologous Bone Marrow Mononuclear Cells for the Treatment of Ischemic Heart Disease
- Effect of Bone Marrow Transplantation in Patients with Critical Limb Ischemia
- Therapeutic Angiogenesis for a Patient with Arteriosclerosis Obliterans by Autologous Transplantation of Bone Marrow Mononuclear Cells
- Autologous Bone Marrow Implantation for Burger's Disease.
「Nielsen BookData」 より